Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma
Learn more about:
Related Clinical Trial
The SHIELD Study-silicosis
Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials
The SHIELD Whole Lung Lavage Study
Efficiency of Pirfenidone for the Reduction of Pulmonary Metabolic, Inflammatory and Fibrogenic Activity in Patients With Silicosis Due to Artificial Stone and Progressive Massive Fibrosis
The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial
Specialized Center of Research in Occupational and Immunologic Lung Disease
Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone)
Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)
Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention
Comprehensive Risk Assessment of People With Silicosis: A Population-based Study
Oscillation Mechanics of the Respiratory System in Never-smoking Patients With Silicosis
Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma